loading...| Preferred Name |
Dalteparin Sodium |
|
| Synonyms |
|
|
| Definitions |
The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C75767 |
|
| Accepted_Therapeutic_Use_For |
reduce the recurrence of symptomatic venous thromboembolism (VTE) |
|
| ALT_DEFINITION |
A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Dalteparin sodium is a type of anticoagulant. |
|
| CAS_Registry |
9041-08-1 |
|
| Chemical_Formula |
(C14H18NO11)n.2(C12H15NO13S)n.3Na.3O3S |
|
| code |
C75767 |
|
| Contributing_Source |
FDA |
|
| definition |
The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. |
|
| FDA_UNII_Code |
12M44VTJ7B |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 |
|
| label |
Dalteparin Sodium |
|
| Legacy Concept Name |
Dalteparin_Sodium |
|
| NCI_Drug_Dictionary_ID |
43290 |
|
| PDQ_Closed_Trial_Search_ID |
43290 |
|
| PDQ_Open_Trial_Search_ID |
43290 |
|
| Preferred_Name |
Dalteparin Sodium |
|
| prefixIRI |
NCIT:C75767 |
|
| prefLabel |
Dalteparin Sodium |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0282471 |
|
| subClassOf |